BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25471640)

  • 1. Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.
    Qvist T; Johansen IS; Pressler T; Høiby N; Andersen AB; Katzenstein TL; Bjerrum S
    BMC Infect Dis; 2014 Dec; 14():655. PubMed ID: 25471640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.
    De P; Amin AG; Graham B; Martiniano SL; Caceres SM; Poch KR; Jones MC; Saavedra MT; Malcolm KC; Nick JA; Chatterjee D
    J Cyst Fibros; 2020 Sep; 19(5):801-807. PubMed ID: 32624408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients.
    Liu D; Gu L; Zhang R; Liu L; Shen Y; Shao Y; Wang J; Sun J; Qi T; Wang Z; Tang Y; Song W; Xun J; Lu H; Chen J
    Int J Infect Dis; 2022 May; 118():65-70. PubMed ID: 35219884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
    BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study.
    Bjerrum S; Kenu E; Lartey M; Newman MJ; Addo KK; Andersen AB; Johansen IS
    BMC Infect Dis; 2015 Oct; 15():407. PubMed ID: 26427365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen detection as a point-of-care test for TB: the case of lipoarabinomannan.
    Swaminathan S; Rekha VV
    Future Microbiol; 2012 May; 7(5):559-64. PubMed ID: 22568711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
    Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
    BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.
    Peter JG; Theron G; van Zyl-Smit R; Haripersad A; Mottay L; Kraus S; Binder A; Meldau R; Hardy A; Dheda K
    Eur Respir J; 2012 Nov; 40(5):1211-20. PubMed ID: 22362849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontuberculous mycobacterial infections in cystic fibrosis.
    Martiniano SL; Nick JA
    Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
    Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
    BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.
    Cavalli Z; Reynaud Q; Bricca R; Nove-Josserand R; Durupt S; Reix P; Perceval M; de Montclos MP; Lina G; Durieu I
    J Cyst Fibros; 2017 Sep; 16(5):579-584. PubMed ID: 28202251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.
    Olivier KN; Weber DJ; Lee JH; Handler A; Tudor G; Molina PL; Tomashefski J; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):835-40. PubMed ID: 12433669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.
    Margileth AM
    Pediatr Infect Dis; 1983; 2(3):225-31. PubMed ID: 6408620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review.
    Nel JS; Lippincott CK; Berhanu R; Spencer DC; Sanne IM; Ive P
    Clin Infect Dis; 2017 Oct; 65(7):1226-1228. PubMed ID: 28575238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.